AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2013
Jun 4, 2013
32870_dirs_2013-06-04_73cafeb8-a980-4df8-af2f-83ade03334bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2013-05-31
Reporting Person: Kramer Robert (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-31 | Common Stock | J | 58249 | — | Acquired | 87560 | Direct |
Footnotes
F1: The acquistion was a result of a redemption of BioPharm L.L.C. membership interests in exchange for shares of the issuer.
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3